Consistent with academic tradition, the sharing of research materials serves to build and expand knowledge. However, the transfer of research materials carries responsibilities that should be recognized and respected by both providers and recipients of these materials.
Assurance of these responsibilities are recorded in Material Transfer Agreements (MTA's). MTA's govern the transfer of such tangible materials as biological materials (cell lines, plasmids, antibodies and vectors), animal models, compounds, equipment, software, and any resulting developments or derivations of such materials.
Typical terms of an MTA define acceptable use of the material, ownership of the original material and any resulting derivatives, publication rights, intellectual property rights, and liability. MTA's are also serve as a valuable tool in meeting federal export control requirements for the transfer of materials among international collaborators. One very simple MTA that is consistent with the terms of the Bayh-Dole Act was generated by the Public Health Service for exchange of federally funded biological research materials by and between academic and non-profit research centers.
The Uniform Biological Material Transfer Agreement (UBMTA) streamlines the review and approval process among institutions who have signed an implementing letter for the UBMTA. For institutions that are not eligible for, or signatories to the UBMTA, ECU has developed standard terms and conditions for the sharing of research materials with both academic and industry collaborators.
ECU's Office of Technology Transfer has delegated authority for negotiation and signature of MTA's. OTT also has a long standing reputation for efficient handling of incoming and outgoing MTA's.
Any incoming research materials requiring signature of an MTA should be directed to OTT.
Any transfer of ECU research materials to entities outside of ECU should be accompanied by
an Industrial MTA or Institutional MTA
To request an NIH account, please contact: NIHTADSupport@mail.nih.gov